文献速递生殖医学

体重指数与GnRH激动剂触发的高危OHSS患者卵母细胞成熟的关系

Association between body mass index and oocyte maturation in patients triggered with GnRH agonist who are at high risk for severe ovarian hyperstimulation syndrome: an observational cohort study.
PubMed 文献 · Reprod Biomed Online · 2019-10-15

前瞻性观察队列研究纳入113例重度OHSS高危患者,用GnRH拮抗剂和重组FSH预处理后,以0.2 mg曲普瑞林触发最终卵母细胞成熟。BMI≥25 kg/m2组成熟卵母细胞数显著少于BMI<25 kg/m2组,且需要更高总剂量的重组FSH。

要点

  • BMI≥25 kg/m2组成熟卵母细胞数显著低于BMI<25 kg/m2组。
  • BMI≥25 kg/m2组所需重组FSH总剂量显著高于BMI<25 kg/m2组。
  • 两组获卵数、受精数及卵母细胞回收率、成熟率、受精率相似。

核心结论

  • 在重度OHSS高危且以标准剂量0.2 mg曲普瑞林触发的女性中,BMI≥25 kg/m2者成熟卵母细胞数显著少于BMI<25 kg/m2者,且所需重组FSH总剂量显著更高。

研究设计与样本

  • 前瞻性观察队列研究,共113例重度OHSS高危患者(至少19个≥11 mm卵泡),用GnRH拮抗剂和重组FSH预处理后,给予0.2 mg曲普瑞林触发最终卵母细胞成熟。
  • 按BMI分为两组:BMI<25 kg/m2组(n=72)和BMI≥25 kg/m2组(n=41)。

主要发现

  • BMI<25 kg/m2组成熟(MII)卵母细胞数为19 [18-21],BMI≥25 kg/m2组为16 [13-20],P=0.029。
  • BMI≥25 kg/m2组所需重组FSH总剂量为1875 [1650-2150] IU,BMI<25 kg/m2组为1650 [1600-1750] IU,P=0.003。
  • 两组获卵数、受精卵母细胞数以及卵母细胞回收率、成熟率和受精率相似。
  • 两组黄体期激素谱不同。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Is body-mass index (BMI) associated with oocyte maturation in women at high risk for developing severe ovarian hyperstimulation syndrome (OHSS) who are triggered with gonadotrophin releasing hormone (GnRH) agonist? DESIGN: Prospective observational cohort study. A total of 113 patients at high risk for severe OHSS (presence of at least 19 follicles ≥11 mm) pre-treated with gonadotrophin releasing hormone (GnRH) antagonists and recombinant FSH were administered 0.2 mg triptorelin to trigger final oocyte maturation. Patients were classified in two groups depending on their BMI: ΒΜΙ less than 25 kg/m2 (n = 72) and ΒΜΙ 25 kg/m2 or over (n = 41). Baseline, ovarian stimulation and embryological characteristics, as well as luteal-phase hormone profiles, were compared in patients classified into the two BMI groups. The main outcome measure was the number of mature oocytes. RESULTS: A significantly higher number of mature (metaphase II) oocytes (19 [18-21] versus 16 [13-20], P = 0.029) was present in women with BMI less than 25 kg/m2 compared with those with BMI 25 kg/m2 or greater. The number of retrieved oocytes, the number of fertilized oocytes, oocyte retrieval, maturation and fertilization rates were similar in the two groups. A significantly higher dose of recombinant FSH was required for patients with BMI 25 kg/m2 or greater compared with patients with BMI less than 25 kg/m2 (1875 [1650-2150] IU versus 1650 [1600-1750] IU, P = 0.003) and the two groups displayed different luteal phase hormonal profiles. CONCLUSIONS: Among women at high risk for developing severe OHSS who are triggered with a standard dose (0.2 mg) of the GnRH agonist triptorelin, women with BMI 25 kg/m2 or greater had significantly fewer mature oocytes, required a higher total dose of recombinant FSH compared with women with BMI less than 25 kg/m2.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Lainas GT, Lainas TG, Sfontouris IA, et al. Association between body mass index and oocyte maturation in patients triggered with GnRH agonist who are at high risk for severe ovarian hyperstimulation syndrome: an observational cohort study. Reprod Biomed Online. 2019. PMID: 31839394. doi:10.1016/j.rbmo.2019.10.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。